Patent · US Active

Method of treating dyskinesia

US9289423B2 · kind B2 · utility

4Cited by

3References

18Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Mary Maral Mouradian · Bethesda, US
Steven P. Braithwaite · Redwood City, US
Michael Voronkov · Cranbury, US

Key dates

Filing date	Apr 26, 2012
Grant date	Mar 22, 2016
Priority date	—
Expiry date	Aug 4, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of treating patients with dyskinesias, by administering a therapeutically effective amount of a dual-action mu-opioid receptor antagonist/kappa-opioid receptor agonist or prodrug thereof to a subject in need thereof, sufficient to mitigate the dyskinesia. Alternatively, a combination of both a mu-opioid receptor antagonist or prodrug thereof, and a kappa-opioid receptor agonist or prodrug thereof can be administered, either together or separately.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.